Virus Like Particles Market Scope And Analysis

  • Report Code : TIPRE00025763
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 163
Buy Now

Virus-Like Particles Market Scope and Key Players Analysis by 2028

Buy Now

Virus-Like Particles Market Report Virus-Like Particles Market Size and Share Virus-Like Particles Market Scope and Analysis

Virus-Like Particles Market Report Scope

Report Attribute Details
Market size in 2021 US$ 4.6 Billion
Market Size by 2028 US$ 7.86 Billion
Global CAGR (2021 - 2028) 7.9%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Product Type
  • Hepatitis
  • Cancer
By Source
  • Yeast
  • Insect cells
By Application
  • Vaccine
  • Therapeutics and Imaging Agents
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Merck Co Inc
  • GlaxoSmithKline plc
  • Pfizer Inc
  • Dynavax Technologies
  • Sanofi
  • Wantai BioPharm
  • Serum Institute of India Pvt Ltd
  • BHARAT BIOTECH
  • LG Chem

    •  

    Virus-Like Particles (VLPs) Market – by Product Type

    • Hepatitis
    • Cancer/HPV
    • Gaucher Disease

    Virus-Like Particles (VLPs) Market – by Source

    • Yeast
    • Insect Cell
    • Plant
    • Others

    Virus-Like Particles (VLPs) Market – by Application

    • Vaccines
    • Therapeutics

    Virus-Like Particles (VLPs) Market – by Geography

    • North America
      • US
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • UK
      • Spain
      • Rest of Europe
    • Asia Pacific (APAC)
      • China
      • India
      • South Korea
      • Japan
      • Australia
      • Rest of APAC
    • Middle East and Africa (MEA)
      • South Africa
      • Saudi Arabia
      • UAE
      • Rest of MEA
    • South and Central America (SCAM)
      • Brazil
      • Argentina
      • Rest of SCAM

    Company Profiles

    • Merck & Co., Inc.
    • GlaxoSmithKline plc.
    • Pfizer Inc.
    • Dynavax Technologies
    • Sanofi
    • Wantai BioPharm
    • Serum Institute of India Pvt. Ltd.
    • BHARAT BIOTECH
    • LG Chem
    • VBI Vaccines Inc.